APNewsBreak: Questions for Medicare in outbreak

WASHINGTON — Questions are being raised about Medicare in the meningitis outbreak that has rekindled doubts about the safety of the nation’s drug supply. The health insurance program for seniors long ago flagged compounded drugs manufactured without Food and Drug Administration oversight as safety …